InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.88
(
-0.13%
)
US TECH 100
17,586.00
(
-0.15%
)
Dow Jones
38,968.16
(
0.22%
)
Brent Oil
83.17
(
0.36%
)
Bitcoin
62,553.33
(
0.35%
)
Post# of 129051
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

U ROCK

Send PM Follow Ignore
Followers 6
Posts 438
Boards Moderated 0
Alias Born 06/21/2011

U ROCK

Re: U ROCK post# 126059

Wednesday, 08/30/2017 8:35:28 PM

Wednesday, August 30, 2017 8:35:28 PM

Post# of 129051
Cannabis Science currently has several research programs underway that have produced initial results that are critical in the Company's early phase cancer drug development plan.

"These initial results are better than expected and are helping Cannabis Science refine our drug development program," stated Dr. Allen Herman, Chief Medical Officer of Cannabis Science.

"Based on our progress to date, we expect to conclude pre-clinical work on a few cannabinoids over the next several months, and begin clinical trials in 2018. This timeline is consistent with the Company's overall development strategy."



These initial results are better than expected.

Better than expected.

WTF

I have high expectations. Shock and awe. Lightning then the Thunder.

The fruits of this plant will heal the nation's once more.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up